Neuromuscular Transmission Monitor Market

Neuromuscular transmission monitor sales will expand through 2035, with nerve stimulating devices/monitors at 58.7% of the product category, accelerography (ACG) at 46.3% of technology demand and hospitals at 63.5% of end user sales in 2025. The market is projected to record a 3.4% CAGR between 2025 and 2035.